Bloodwork question about armodafinil. Baseline, two months in, and the numbers moved in a direction I did not expect.
I would rather have a narrow conclusion and be right than a broad one and be interesting.
What surprised me is how much of the perceived benefit was routine and attention rather than pharmacology.
Two weeks is not enough time to attribute anything to a compound unless the effect is dramatic.
Posting to be argued with, mainly.
Narrow conclusion.
Name the active ingredient, not just the brand. It makes these threads searchable years later.
Sleep, food, or the compound? Yes.
Baseline first. Without a baseline the after picture is decoration. Appetite suppression was my main issue with armodafinil too.
My rule, after years of this: if it cannot survive being written down with the numbers attached, it is marketing.
Sleep, food, or the compound? Yes. Not on armodafinil but the pattern is familiar.
Stupid question: how do you know whether what is in the vial matches the label at all?
How long before you can reasonably say something is or is not doing anything?
Most of the popular protocol is borrowed from a clinical population and applied to healthy people without comment.
Sterility is the part people wave through and it is the part that actually bites.
Narrow conclusion. Same for me with armodafinil, unfortunately.
What is the first thing you would read if you were starting from zero?
A plausible mechanism is not an outcome, and this class is the textbook example.
Stupid question: how do you know whether what is in the vial matches the label at all?